Hesk - i'm starting to think Roche may not eventuate aswell
Firstly i was under the impression that their decision of where to from here was expected by the end of 2011 although as is always the case in the sector evrything takes that bit longer so a delay wasn't really something that pushed concern.
However we all know the FinanceNetwork interviews are largely scripted by the companies themselves outlining the questions they would like to be asked & inturn having their answers already scripted. Questions where delivered firstly in relation to the Janssen deal just signed & then moved to progress for Meddimune/AstraZeneca & Pfizer partnerships..... But no Roche ?
Leaves 2 options IMO - either Roche has buckled the belt even tighter in the final stages from high confidentiality with very minimal release to a complete lock down until it's finalized or the partnership has failed to meet it's target. Although i still think if Roche had walked they would have to of updated the market by now.
PYC Price at posting:
3.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)